Is CareDx Inc (CDNA) overvalued? · rev $333.8M
CareDx Inc (CDNA) is a diagnostics & research company listed on US.
This page asks whether CareDx Inc (CDNA) looks expensive on cached numbers — not a short thesis.
Latest reported CDNA revenue for 2024-12-31 was $333.8M. Net income was $52.5M. Revenue was up 19.1% from 2023-12-31 to 2024-12-31. CDNA currently screens at market cap $1.18B.
CDNA currently screens at market cap $1.18B. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.
If the next CDNA 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.
Not investment advice. Use the CDNA stock page for the full model, not this heading.
Not investment advice.